Impact of vulvovaginal health on postmenopausal women: a review of surveys on symptoms of vulvovaginal atrophy

被引:163
|
作者
Parish, Sharon J. [1 ]
Nappi, Rossella E. [2 ]
Krychman, Michael L. [3 ]
Kellogg-Spadt, Susan [4 ]
Simon, James A. [5 ]
Goldstein, Jeffrey A. [6 ]
Kingsberg, Sheryl A. [7 ,8 ]
机构
[1] Albert Einstein Coll Med, Bronx, NY 10467 USA
[2] Univ Pavia, IRCCS Policlin San Matteo Univ, Dept Obstet & Gynecol, Pavia, Italy
[3] Univ Calif Irvine, Southern Calif Ctr Sexual Hlth & Survivorship, Med & Clin Fac, Irvine, CA 92717 USA
[4] Pelv & Sexual Hlth Inst, Philadelphia, PA USA
[5] George Washington Univ, Obstet & Gynecol, Washington, DC 20052 USA
[6] Novo Nordisk Inc, Princeton, NJ USA
[7] Case Western Reserve Univ, Sch Med, Dept Reprod Biol, Cleveland, OH 44106 USA
[8] Case Western Reserve Univ, Sch Med, Dept Psychiat, Cleveland, OH 44106 USA
关键词
health care professional; hypoactive sexual desire disorder; local vaginal estrogen therapy; quality of life; urinary tract infection; vulvovaginal atrophy;
D O I
10.2147/IJWH.S44579
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Several recent, large-scale studies have provided valuable insights into patient perspectives on postmenopausal vulvovaginal health. Symptoms of vulvovaginal atrophy, which include dryness, irritation, itching, dysuria, and dyspareunia, can adversely affect interpersonal relationships, quality of life, and sexual function. While approximately half of postmenopausal women report these symptoms, far fewer seek treatment, often because they are uninformed about hypoestrogenic postmenopausal vulvovaginal changes and the availability of safe, - effective, and well-tolerated treatments, particularly local vaginal estrogen therapy. Because women hesitate to seek help for symptoms, a proactive approach to conversations about vulvovaginal discomfort would improve diagnosis and treatment.
引用
收藏
页码:437 / 447
页数:11
相关论文
共 50 条
  • [21] Impact Of Vulvovaginal Atrophy Of Menopause In Spanish Women: Prevalence And Symptoms According To The EVES Study
    Palacios, Santiago
    Gonzalez, Silvia P.
    Fernandez-Abellan, Micaela
    Manubens, Montserrat
    Garcia-Alfaro, Pascual
    Argudo Prieto, C.
    Baquedano Mainar, L.
    Calleja Abu-Amshah, J.
    Cancelo Hidalgo, M. J.
    Castelo-Branco i Flores, C.
    Coronado Martin, P.
    Correa Rancel, M.
    Fernandez Abellan, M.
    Fernandez Moya, J. M.
    Garcia Alfaro, P.
    Gonzalez Fernandez, M.
    Gonzalez Rodriguez, S.
    Iglesias Bravo, E.
    Llaneza Coto, P.
    Manubens Grau, M.
    Marin Sanchez, P.
    Ladron de Guevara, N. Mendoza
    Otero Garcia-Ramos, B.
    Palacios, S.
    Presa Lorite, J. C.
    Sanchez Borrego, R.
    Sanchez Mendez, S.
    Vazquez Fernandez, F.
    SEXUAL MEDICINE, 2019, 7 (02): : 207 - 216
  • [22] EFFECT OF INTRAVAGINAL PRASTERONE ON SEXUAL DYSFUNCTION IN POSTMENOPAUSAL WOMEN WITH VULVOVAGINAL ATROPHY
    Labrie, F.
    DeRogatis, L.
    Archer, D. F.
    Martel, C.
    JOURNAL OF SEXUAL MEDICINE, 2016, 13 (06): : S244 - S244
  • [23] Clinical manifestations and evaluation of postmenopausal vulvovaginal atrophy
    Perez-Lopez, Faustino R.
    Vieira-Baptista, Pedro
    Phillips, Nancy
    Cohen-Sacher, Bina
    Fialho, Susana C. A. V.
    Stockdale, Colleen K.
    GYNECOLOGICAL ENDOCRINOLOGY, 2021, 37 (08) : 740 - 745
  • [24] Prasterone: A Review in Vulvovaginal Atrophy
    Heo, Young-A
    DRUGS & AGING, 2019, 36 (08) : 781 - 788
  • [25] The Vulvovaginal Atrophy Questionnaire (VVAQ): A Novel Patient-Reported Outcome (PRO) for Assessing Symptoms of Vulvovaginal Atrophy in Menopausal Women
    Shifren, Jan
    Portman, David
    Krychman, Michael
    Simon, James
    Kingsberg, Sheryl A.
    Zincavage, Rebekah
    Magnavita, Ashley
    Rosen, Raymond C.
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2017, 24 (12): : 1434 - 1435
  • [26] Effect of Intravaginal Prasterone on Sexual Dysfunction in Postmenopausal Women with Vulvovaginal Atrophy
    Labrie, Fernand
    Derogatis, Leonard
    Archer, David F.
    Koltun, William
    Vachon, Andree
    Young, Douglas
    Frenette, Louise
    Portman, David
    Montesino, Marlene
    Cote, Isabelle
    Parent, Julie
    Lavoie, Lyne
    Beauregard, Adam
    Martel, Celine
    Vaillancourt, Mario
    Balser, John
    Moyneur, Erick
    JOURNAL OF SEXUAL MEDICINE, 2015, 12 (12): : 2401 - 2412
  • [27] Vulvovaginal atrophy in women after cancer
    Cox, P.
    Panay, N.
    CLIMACTERIC, 2019, 22 (06) : 565 - 571
  • [28] Vaginal and systemic cytokines in postmenopausal women with and without symptoms of vulvovaginal irritation
    Stute, Petra
    Kollmann, Zahraa
    Bersinger, Nick
    von Wolff, Michael
    Thurman, Andrea R.
    Archer, David F.
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2013, 20 (12): : 1332 - 1332
  • [29] Effectiveness of hyaluronate-based pessaries in the treatment of vulvovaginal atrophy in postmenopausal women
    Nappi, R. E.
    Kotek, M.
    Brest'ansky, A.
    Giordan, N.
    Tramentozzi, E.
    CLIMACTERIC, 2020, 23 (05) : 519 - 524
  • [30] Microdose transdermal estrogen therapy for relief of vulvovaginal symptoms in postmenopausal women
    Bachmann, Gloria A.
    Schaefers, Matthias
    Uddin, Alkaz
    Utian, Wulf H.
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2009, 16 (05): : 877 - 882